CH621554A5 - - Google Patents

Download PDF

Info

Publication number
CH621554A5
CH621554A5 CH455376A CH455376A CH621554A5 CH 621554 A5 CH621554 A5 CH 621554A5 CH 455376 A CH455376 A CH 455376A CH 455376 A CH455376 A CH 455376A CH 621554 A5 CH621554 A5 CH 621554A5
Authority
CH
Switzerland
Prior art keywords
alpha
sodium
methyl
formyl
gram
Prior art date
Application number
CH455376A
Other languages
German (de)
English (en)
Inventor
Kuo Shang Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH621554A5 publication Critical patent/CH621554A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CH455376A 1975-04-11 1976-04-09 CH621554A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/567,324 US4006138A (en) 1975-04-11 1975-04-11 Crystalline form of sodium O-formylcefamandole

Publications (1)

Publication Number Publication Date
CH621554A5 true CH621554A5 (xx) 1981-02-13

Family

ID=24266692

Family Applications (1)

Application Number Title Priority Date Filing Date
CH455376A CH621554A5 (xx) 1975-04-11 1976-04-09

Country Status (31)

Country Link
US (1) US4006138A (xx)
JP (1) JPS51123812A (xx)
AR (1) AR210880A1 (xx)
AT (1) AT343806B (xx)
AU (1) AU500013B2 (xx)
BE (1) BE840179A (xx)
CA (1) CA1045114A (xx)
CH (1) CH621554A5 (xx)
CS (1) CS191970B2 (xx)
DD (1) DD125950A5 (xx)
DE (1) DE2614669C2 (xx)
DK (1) DK148022C (xx)
ES (1) ES446907A1 (xx)
FI (1) FI65069C (xx)
FR (1) FR2306698A1 (xx)
GB (1) GB1546898A (xx)
GR (1) GR59912B (xx)
HU (1) HU175592B (xx)
IL (1) IL49100A (xx)
LU (1) LU74740A1 (xx)
MX (1) MX3687E (xx)
NL (1) NL184258C (xx)
NO (1) NO151748C (xx)
OA (1) OA05290A (xx)
PL (1) PL104803B1 (xx)
PT (1) PT64917B (xx)
RO (1) RO68501A (xx)
SE (1) SE435290B (xx)
SU (1) SU668608A3 (xx)
YU (1) YU40643B (xx)
ZA (1) ZA761103B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7503274L (sv) * 1974-04-11 1975-10-13 Ciba Geigy Ag Cefalosporin
US4085277A (en) * 1975-01-30 1978-04-18 Fujisawa Pharmaceutical Co., Ltd. 7(2-Phenyl or thienyl-2-isonicotinoyloxyacetamido)-3-(1-methyl-1-H tetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid
FR2400519A1 (fr) * 1977-08-17 1979-03-16 Roussel Uclaf Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4946838A (en) * 1981-07-13 1990-08-07 E. R. Squibb & Sons, Inc. Crystalline anhydrous aztreonam
EP0432297A1 (en) * 1989-12-13 1991-06-19 Technologitschen Kombinat Sa Promischlena Mikrobiologia A method for the preparation of the sodium salt of O-formyl cefamandole
US5492903A (en) * 1990-06-19 1996-02-20 Takeda Chemical Industries Ltd. Crystalline esters of (+)-(5R, 6S)-6-[(R)-1-hydroxyethyl]-3-(3-pyridyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]he
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
WO2013057196A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of cefamandole nafate
CN104530086B (zh) * 2014-12-16 2015-12-09 天津大学 头孢孟多酯钠化合物的新晶型及其结晶制备方法
CN105037392A (zh) * 2015-08-13 2015-11-11 青岛蓝盛洋医药生物科技有限责任公司 一种杀菌药物头孢孟多酯钠化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887551A (en) * 1964-11-04 1975-06-03 Glaxo Lab Ltd Crystalline forms of cephaloridine
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
NL184258B (nl) 1989-01-02
HU175592B (hu) 1980-09-28
AR210880A1 (es) 1977-09-30
DE2614669A1 (de) 1976-10-21
FR2306698A1 (fr) 1976-11-05
BE840179A (fr) 1976-09-30
GB1546898A (en) 1979-05-31
AT343806B (de) 1978-06-26
NO151748B (no) 1985-02-18
NO761017L (xx) 1976-10-12
US4006138A (en) 1977-02-01
ZA761103B (en) 1977-10-26
ATA258476A (de) 1977-10-15
JPS51123812A (en) 1976-10-28
CS191970B2 (en) 1979-07-31
DK150676A (da) 1976-10-12
CA1045114A (en) 1978-12-26
YU40643B (en) 1986-04-30
SE435290B (sv) 1984-09-17
MX3687E (es) 1981-04-29
PL104803B1 (pl) 1979-09-29
NL7603660A (nl) 1976-10-13
FI760788A (xx) 1976-10-12
PT64917A (en) 1976-04-01
ES446907A1 (es) 1977-09-16
SU668608A3 (ru) 1979-06-15
FR2306698B1 (xx) 1979-10-05
IL49100A0 (en) 1976-04-30
GR59912B (en) 1978-03-20
SE7602565L (sv) 1976-10-12
LU74740A1 (xx) 1976-11-11
OA05290A (fr) 1981-02-28
PT64917B (en) 1977-08-24
NL184258C (nl) 1989-06-01
YU79276A (en) 1982-10-31
AU1143576A (en) 1977-09-01
FI65069B (fi) 1983-11-30
FI65069C (fi) 1984-03-12
IL49100A (en) 1979-03-12
DK148022C (da) 1985-07-22
DK148022B (da) 1985-02-04
DE2614669C2 (de) 1984-09-27
NO151748C (no) 1985-06-05
RO68501A (ro) 1981-04-30
DD125950A5 (xx) 1977-06-01
AU500013B2 (en) 1979-05-10
JPS6110474B2 (xx) 1986-03-29

Similar Documents

Publication Publication Date Title
DD271705A5 (de) Verfahren zum herstellen von azithromycin-dihydrat
DE1668994C3 (xx)
DD215552A5 (de) Verfahren zur herstellung von kristallisierten cephem-saeureadditionssalzen
DE2614669C2 (de) Gamma-kristalline wasserfreie Form von 7-(D-alpha-Formyloxy-alpha-phenylacetamido)-3-(1-methyl-1H-tetrazol-5- ylthiomethyl)-3-cephem-4-natriumcarboxylat und Verfahren zu ihrer Herstellung
DE60215213T3 (de) Herstellung von levofloxacin-hemihydrat
EP0711774B1 (de) Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
EP0280157B1 (de) Kristallisierte Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
DE2953969C2 (xx)
DE2738711C2 (de) Salze des Cefotiams
DE2225694C3 (de) Cephalosporinverbindungen und Verfahren zu deren Herstellung
DD261163A5 (de) Verfahren zur reinigung von cephalosporin-antibiotika
DE1143817C2 (de) Verfahren zur Herstellung von 6-Phenoxyacylamidopenicillansaeure-derivaten und von nicht giftigen Salzen derselben
DE3235372C2 (xx)
DE60204826T2 (de) Verfahren zur Herstellung von Natriumsalz der D-6-[(alpha-4-(Ethyl-2,3-dioxo-1-piperazinocarbonyl-amino)phenylacetamido]-penicillansäure
DE2655130C3 (de) Eine praktisch lösungsmittelfreie Kristallform des Cefacetril-Natriumsalzes
CH492737A (de) Verfahren zur Herstellung von Cephalosporin-CA-Antibiotica
EP0282531B1 (de) Stabile, kristalline form eines cefalosporin-zwischenproduktes
DE2043817C3 (de) 1,4-Dihydro-3-carboxy-cyclopentano-(h)-chinolon-(4)-derivate, Verfahren zu deren Herstellung sowie deren Verwendung zur Bekämpfung antibakterieller Erkrankungen
EP0125542B1 (de) Verfahren zur Herstellung von Hydrochloriden
DE3102984A1 (de) Verfahren zur herstellung von cysteamin-s-substituierten verbindungen und deren derivaten
DE2011885C3 (de) 1,4-Dihydro-3-carboxy-cyclopentano (h)-chinolon-(4)-derivate, Verfahren zur Herstellung derselben und ihre Verwendung
DE1545838C3 (de) 7-(2-Azidooctanamido)-cephalosporansäure, deren Salze und Verfahren zur Herstellung dieser Verbindungen
AT387389B (de) Verfahren zur herstellung einer neuen kristallinen, stabilen form des syn-isomeren des (6r, 7r)-7-((2-(2-amino-4-thiazolyl)-(z)-2(1-tert.butoxycarbonyl-1-methylethoxy)imino)
DE955592C (de) Verfahren zur Herstellung von in Wasser schwer loeslichen kristallisierbaren Mischsalzen des Dihydrostreptomycins
DE953432C (de) Verfahren zur Reinigung von chlortetracyclinhaltigen Stoffen

Legal Events

Date Code Title Description
PL Patent ceased